Evidence map›Paper›PMID 33569630›Full record

ArticleCancer immunology, immunotherapy : CII2021

The cytokine milieu compromises functional capacity of tumor-infiltrating plasmacytoid dendritic cells in HPV-negative but not in HPV-positive HNSCC.

Vladimír Koucký, Kamila Hladíková, Eliška Táborská, Jan Bouček, Marek Grega, Radek Špíšek, Anna Fialová

Open access · greenAbstract read
In one paragraph

Article in Cancer immunology, immunotherapy : CII, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Type I conventional dendritic cells and CD8Frontiers in immunology · 2024
    Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Type I Interferon Production of Plasmacytoid Dendritic Cells under Control.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Vladimír Koucký, Sotio, Prague, Czech Republic. koucky@sotio.com.
Kamila Hladíková, Sotio, Prague, Czech Republic.
Eliška Táborská, Sotio, Prague, Czech Republic.
Jan BoučekDepartment of Otorhinolaryngology and Head and Neck Surgery, First Medical Faculty, Motol University Hospital, Prague, Czech Republic.
Marek GregaDepartment of Pathology and Molecular Medicine, Second Medical Faculty, Motol University Hospital, Prague, Czech Republic.
Radek Špíšek, Sotio, Prague, Czech Republic.
Anna Fialová, Sotio, Prague, Czech Republic. fialova@sotio.com.ORCID https://orcid.org/0000-0003-1436-5142
Sotio (Czechia) · CZUniversity Hospital in Motol · CZ

Funding

Grantová Agentura, Univerzita Karlova 668217
6 · The paper itself

Abstract

Plasmacytoid dendritic cells (pDCs) are the most potent type I interferon-producing cells and play an important role in antiviral immunity. Tumor-infiltrating pDCs were shown to be predominantly pro-tumorigenic, with reduced ability to produce interferon alpha (IFNα) and confirmed capacity to prime regulatory T cells (Tregs) by the ICOS/ICOS-L pathway. Because a significant number of HNSCCs are induced by human papillomaviruses and show markedly different immune profiles than non-virally induced tumors, we compared the phenotype and functional capacity of HNSCC-infiltrating pDCs to the HPV status of the tumor. We observed a reduced capacity of pDCs to produce IFNα upon toll-like receptor activation in HPV-negative samples and a rather uncompromised functionality in HPV-associated tumors. Additionally, supernatants from non-virally induced but not HPV-associated tumor cell suspensions significantly inhibited IFNα production by peripheral blood-derived pDCs. We identified IL-10 and TNFα as the soluble pDC-suppressive factors with the highest variability between HPV-negative and HPV-positive tumor-derived supernatants. Additionally, we observed a positive correlation of tumor-infiltrating pDCs with Tregs in HPV-negative samples but not in virally induced tumors. Overall, our study indicates that the immunosuppressive cytokine milieu rich in IL-10 and TNFα in HPV-negative but not in HPV-positive HNSCC significantly affects the functional capacity of tumor-infiltrating pDCs, and such dysfunctional pDCs may further support the immunosuppressive tumor microenvironment by promoting the expansion of Tregs in the tumor tissue.

Indexed as

Tumor MicroenvironmentBiomarkersCase-Control StudiesCell Transformation, ViralCytokinesDendritic CellsDisease SusceptibilityGene ExpressionHumansInterferon-alphaPapillomavirus InfectionsSquamous Cell Carcinoma of Head and NeckT-Lymphocytes, RegulatoryT-Lymphocyte SubsetsBiomarkersCytokinesInterferon-alphaHead and neck cancerHuman papillomavirusInterferon alphaPlasmacytoid dendritic cells

Identifiers

PMID33569630
PMCPMC10992977
OpenAlexW3128737955

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.